Clinical trial
Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High…
NCT00003858 · Alliance for Clinical Trials in Oncology, Other · Withdrawn
Key facts
| NCT number | NCT00003858 |
|---|---|
| Title | Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence |
| Official title | A Phase II Trial of Adjuvant Mitoxantrone (NSC #301739) for High Risk Patients Following Radical Prostatectomy |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | mitoxantrone hydrochloride |
| Enrollment | 0 |
| First posted | Sep 14, 2004 |
| Last update posted | Jul 13, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: